ScholarLens Back to search
2023•Unpublished venueOpen access

Supplementary Figure S3: Effect of ipilimumab on FOXP3+ cells in human tumors from Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers

Anu Sharma, Sumit K. Subudhi, Jorge Blando, Jorge Scutti, Luis M. Vence, Jennifer A. Wargo, James P. Allison, Antoni Ribas, Padmanee Sharma

Open full text 0 citations

Abstract

The representative IHC micrographs for FOXP3+ cells from stage-matched untreated and Ipi-treated metastatic melanoma, bladder and prostate tumors at 10X and 20X magnifications (inset).

Open-access reader

About this research paper

What this paper is about

The representative IHC micrographs for FOXP3+ cells from stage-matched untreated and Ipi-treated metastatic melanoma, bladder and prostate tumors at 10X and 20X magnifications (inset).

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The representative IHC micrographs for FOXP3+ cells from stage-matched untreated and Ipi-treated metastatic melanoma, bladder and prostate tumors at 10X and 20X magnifications (inset).

Key concepts: FOXP3, Ipilimumab, Immunotherapy, CTLA-4, Melanoma, Cancer research, Medicine, Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Supplementary Figure S3: Effect of ipilimumab on FOXP3+ cells in human tumors from Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers — Research Paper | ScholarLens